Q2 2018 Holdings
Filed 2018-08-14 | 8 holdings | $187.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Axogen Inc(AXGN) | COM | 05463X106 | $186.5M | 3,711,111 | 99.5% |
| Acura Pharmaceuticals Inc(ACUR) | COM | 00509L802 | $704.0K | 1,956,397 | 0.4% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $91.7K | 3,342,047 | 0.0% |
| Corium | COM | 21887L107 | $74.9K | 9,353,304 | 0.0% |
| Eyepoint | COM | 74440J101 | $53.0K | 25,470,390 | 0.0% |
| Endologix Inc | COM | 29266S106 | $13.6K | 1,257,468 | 0.0% |
| Medicinova Inc(MNOV) | COM | 58468P206 | $9.3K | 1,170,370 | 0.0% |
| Catalyst | COM | 14888D109 | $933 | 78,622 | 0.0% |